BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Lymphocyte
,
Nosology
,
Aspirin
,
rs2230926
,
CXCL2
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Yes1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Parotid gland
Colon mucosa
Basophil of peripheral blood
Ileum mucosa
Sigmoid colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Raynaud's phenomenon
Pneumocystosis
Macrocephaly
Sjögren's syndrome
Helicobacter pylori gastrointestinal tract infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
acetylsalicylsalicylic acid
2,2-bis(bromomethyl)-1,3-propanediol
4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl ethylene diamine
quintozene
enterotoxin I, staphylococcal
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR142
ARGLU1
GDAP1
SIX4
EXT2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
YES1: A Novel Therapeutic Target and Biomarker in Cancer.
YES1 Is a Druggable Oncogenic Target in SCLC.
Downregulation of circ-YES1 suppresses NSCLC migration and proliferation through the miR-142-3p-HMGB…
YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK …
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediator…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ